Al-Razi Medical Company (TADAWUL:9572)
Saudi Arabia
· Delayed Price · Currency is SAR
27.00
+1.90 (7.57%)
At close: Mar 9, 2026
Al-Razi Medical Company Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 41 | 90 | 91 | - | - |
| Market Cap Growth | -61.10% | -1.34% | - | - | - |
| Enterprise Value | 54 | 98 | 97 | - | - |
| Last Close Price | 27.00 | 59.00 | 59.80 | - | - |
| PE Ratio | 145.68 | 509.93 | 132.51 | - | - |
| PS Ratio | 0.64 | 1.46 | 1.48 | - | - |
| PB Ratio | 1.80 | 3.96 | 4.06 | - | - |
| P/TBV Ratio | 1.83 | 4.03 | 4.15 | - | - |
| P/FCF Ratio | 50.52 | 81.55 | 91.19 | - | - |
| P/OCF Ratio | 10.43 | 18.09 | 15.73 | - | - |
| EV/Sales Ratio | 0.84 | 1.60 | 1.59 | - | - |
| EV/EBITDA Ratio | 10.52 | 36.62 | 32.66 | - | - |
| EV/EBIT Ratio | 38.05 | 94.35 | 62.66 | - | - |
| EV/FCF Ratio | 66.26 | 89.31 | 97.71 | - | - |
| Debt / Equity Ratio | 0.58 | 0.38 | 0.48 | 0.32 | 0.27 |
| Debt / EBITDA Ratio | 2.56 | 1.78 | 2.04 | 1.45 | 1.49 |
| Debt / FCF Ratio | 16.11 | 7.86 | 10.73 | - | - |
| Net Debt / Equity Ratio | 0.56 | 0.34 | 0.44 | 0.26 | -0.05 |
| Net Debt / EBITDA Ratio | 4.08 | 2.88 | 3.30 | 1.68 | -0.36 |
| Net Debt / FCF Ratio | 15.75 | 7.03 | 9.87 | -9.51 | 0.43 |
| Asset Turnover | 1.34 | 1.42 | 1.39 | 1.26 | - |
| Inventory Turnover | 2.21 | 2.23 | 1.98 | 1.84 | - |
| Quick Ratio | 0.29 | 0.27 | 0.14 | 0.19 | 0.89 |
| Current Ratio | 1.56 | 1.92 | 1.79 | 2.07 | 2.61 |
| Return on Equity (ROE) | 1.25% | 0.78% | 2.99% | 8.43% | - |
| Return on Assets (ROA) | 1.85% | 1.51% | 2.20% | 3.88% | - |
| Return on Invested Capital (ROIC) | 1.71% | 1.10% | 3.17% | 8.12% | 8.99% |
| Return on Capital Employed (ROCE) | 4.20% | 3.50% | 5.00% | 8.60% | 8.20% |
| Earnings Yield | 0.69% | 0.20% | 0.76% | - | - |
| FCF Yield | 1.98% | 1.23% | 1.10% | - | - |
| Dividend Yield | 6.32% | - | 2.65% | - | - |
| Payout Ratio | - | - | 351.72% | 93.81% | - |
| Total Shareholder Return | 6.32% | - | 2.65% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.